Correction: Clinical Impact of MALDI-TOF MS Identification and Rapid Susceptibility Testing on Adequate Antimicrobial Treatment in Sepsis with Positive Blood Cultures.
[This corrects the article DOI: 10.1371/journal.pone.0156299.].
Main Authors: | Alexia Verroken, Lydwine Defourny, Olivier le Polain de Waroux, Leïla Belkhir, Pierre-François Laterre, Michel Delmée, Youri Glupczynski |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5033485?pdf=render |
Similar Items
-
Clinical Impact of MALDI-TOF MS Identification and Rapid Susceptibility Testing on Adequate Antimicrobial Treatment in Sepsis with Positive Blood Cultures.
by: Alexia Verroken, et al.
Published: (2016-01-01) -
MALDI-TOF MS monitoring of PBMC activation status in sepsis
by: Aurélie Daumas, et al.
Published: (2018-07-01) -
Editorial: MALDI-TOF MS Application for Susceptibility Testing of Microorganisms
by: Karsten Becker, et al.
Published: (2020-11-01) -
Investigating Antifungal Susceptibility in Candida Species With MALDI-TOF MS-Based Assays
by: Margot Delavy, et al.
Published: (2019-02-01) -
Rapid antibiotic susceptibility testing on blood cultures using MALDI-TOF MS.
by: Marlène Sauget, et al.
Published: (2018-01-01)